{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:51:14Z","timestamp":1773168674755,"version":"3.50.1"},"reference-count":135,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim of this review was to provide an overview of the role of novel biomarkers in metabolic syndrome, their association with cardiovascular risk and the impact of bariatric surgery on these biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Metabolic syndrome encompasses an intricate network of health problems, and its constituents extend beyond the components of its operational definition. Obesity-related dyslipidaemia not only leads to quantitative changes in lipoprotein concentration but also alteration in qualitative composition of various lipoprotein subfractions, including HDL particles, rendering them proatherogenic. This is compounded by the concurrent existence of obstructive sleep apnoea (OSA) and nonalcoholic fatty liver disease (NAFLD), which pave the common pathway to inflammation and oxidative stress culminating in heightened atherosclerotic cardiovascular disease (ASCVD) risk. Bariatric surgery is an exceptional modality to reverse both conventional and less recognised aspects of metabolic syndrome. It reduces the burden of atherosclerosis by ameliorating the impact of obesity and its related complications (OSA, NAFLD) on quantitative and qualitative composition of lipoproteins, ultimately improving endothelial function and cardiovascular morbidity and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Several novel biomarkers, which are not traditionally considered as components of metabolic syndrome play a crucial role in determining ASCVD risk in metabolic syndrome. Due to their independent association with ASCVD, it is imperative that these are addressed. Bariatric surgery is a widely recognized intervention to improve the conventional risk factors associated with metabolic syndrome; however, it also serves as an effective treatment to optimize novel biomarkers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000889","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:20:22Z","timestamp":1691662822000},"page":"221-233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery"],"prefix":"10.1097","volume":"34","author":[{"given":"Bilal","family":"Bashir","sequence":"first","affiliation":[{"name":"Faculty of Biology, Medicine and Health, University of Manchester"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Peter Mount Building, Manchester University NHS Foundation Trust"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safwaan","family":"Adam","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan H.","family":"Ho","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zara","family":"Linn","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, University of Manchester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Durrington","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, University of Manchester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, University of Manchester"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Peter Mount Building, Manchester University NHS Foundation Trust"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1479164119828899","article-title":"The Reaven syndrome: an historical perspective","volume":"16","author":"Soran","year":"2019","journal-title":"Diab Vasc Dis Res"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0026-0495(87)90063-1","article-title":"Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity","volume":"36","author":"Fujioka","year":"1987","journal-title":"Metabolism"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.1989.00390070054005","article-title":"The deadly Quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension","volume":"149","author":"Kaplan","year":"1989","journal-title":"Arch Intern Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archinternmed.2009.551","article-title":"The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis","volume":"170","author":"Bayturan","year":"2010","journal-title":"Arch Intern Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1097\/MD.0000000000000212","article-title":"Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study","volume":"93","author":"L\u00f3pez-Su\u00e1rez","year":"2014","journal-title":"Medicine"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2047487319886404","article-title":"The metabolic syndrome: what is it and how should it be managed?","volume":"26","author":"Nilsson","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/met.2019.0005","article-title":"The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients","volume":"17","author":"Pekgor","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5551\/jat.7922","article-title":"The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism","volume":"18","author":"Matsuzawa","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2337\/dbi19-0007","article-title":"Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease","volume":"69","author":"Chait","year":"2020","journal-title":"Diabetes"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MOL.0b013e328306a057","article-title":"Glycation as an atherogenic modification of LDL","volume":"19","author":"Younis","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2008.621","article-title":"Nonfasting triglycerides and risk of ischemic stroke in the general population","volume":"300","author":"Freiberg","year":"2008","journal-title":"JAMA"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.0000145615.33955.83","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region","volume":"110","author":"Patel","year":"2004","journal-title":"Circulation"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-022-01525-5","article-title":"Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study","volume":"21","author":"Patel","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"e015801","DOI":"10.1161\/JAHA.119.015801","article-title":"Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk Italian population: the TG-REAL retrospective cohort analysis","volume":"9","author":"Arca","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/2047487319898571","article-title":"Association of four lipid components with mortality, myocardial infarction, and stroke in statin-na\u00efve young adults: a nationwide cohort study","volume":"27","author":"Lee","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe hypertriglyceridaemia and chylomicronaemia syndrome: causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MOL.0b013e328355ca25","article-title":"HDL functionality","volume":"23","author":"Soran","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.ATV.0000022015.97341.3A","article-title":"Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study","volume":"22","author":"Kuller","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"12573","DOI":"10.1038\/s41598-021-90346-9","article-title":"The role of abnormalities of lipoproteins and HDL functionality in small fibre dysfunction in people with severe obesity","volume":"11","author":"Azmi","year":"2021","journal-title":"Sci Rep"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/clinem\/dgac244","article-title":"Bariatric surgery-induced high-density lipoprotein functionality enhancement is associated with reduced inflammation","volume":"107","author":"Adam","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1210\/jc.2017-00933","article-title":"Adiponectin predicts high-density lipoprotein cholesterol efflux capacity in adults irrespective of body mass index and fat distribution","volume":"102","author":"Marsche","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fphys.2018.01238","article-title":"Meta-analysis of adiponectin as a biomarker for the detection of metabolic syndrome","volume":"9","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"e004808","DOI":"10.1161\/JAHA.116.004808","article-title":"Association of cholesterol efflux capacity with clinical features of metabolic syndrome: relevance to atherosclerosis","volume":"5","author":"Gall","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/jcm10081716","article-title":"Changes in the composition and function of lipoproteins after bariatric surgery in patients with severe obesity","volume":"10","author":"Genua","year":"2021","journal-title":"J Clin Med"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"1065967","DOI":"10.3389\/fcvm.2023.1065967","article-title":"Paraoxonase 1 and atherosclerosis","volume":"10","author":"Durrington","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2015.00222","article-title":"Antioxidant properties of HDL","volume":"6","author":"Soran","year":"2015","journal-title":"Front Pharmacol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4093\/dmj.2015.39.1.59","article-title":"Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus","volume":"39","author":"G\u00f3mez Garc\u00eda","year":"2015","journal-title":"Diabetes Metab J"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"2058738419827154","DOI":"10.1177\/2058738419827154","article-title":"Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases","volume":"33","author":"De Stefano","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1194\/jlr.RA120000963","article-title":"High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity","volume":"62","author":"Ho","year":"2021","journal-title":"J Lipid Res"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41598-017-07821-5","article-title":"Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients","volume":"7","author":"Carnuta","year":"2017","journal-title":"Sci Rep"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/eurheartj\/ehq055","article-title":"Antiapolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction","volume":"31","author":"Vuilleumier","year":"2010","journal-title":"Eur Heart J"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fimmu.2017.00437","article-title":"Anti-apolipoprotein A-1 IgG predict all-cause mortality and are associated with Fc receptor-like 3 polymorphisms","volume":"8","author":"Antiochos","year":"2017","journal-title":"Front Immunol"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"243158","DOI":"10.1155\/2012\/243158","article-title":"Antiapolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals","volume":"2012","author":"Quercioli","year":"2012","journal-title":"Mediators Inflamm"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1744-9987.2012.01102.x","article-title":"High prevalence of antiapolipoprotein\/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage","volume":"16","author":"Pruijm","year":"2012","journal-title":"Ther Apher Dial"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diabetes.53.4.1068","article-title":"The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well functioning elderly people in the health, aging, and body composition cohort","volume":"53","author":"Holvoet","year":"2004","journal-title":"Diabetes"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Mehta","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1373\/clinchem.2009.140707","article-title":"LOX index, a novel predictive biochemical marker for coronary heart disease and stroke","volume":"56","author":"Inoue","year":"2010","journal-title":"Clin Chem"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2022.07.036","article-title":"Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis","volume":"623","author":"Tomar","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1258\/acb.2011.010277","article-title":"Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients","volume":"48","author":"Soran","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ecl.2022.02.005","article-title":"Assessment of cardiovascular disease risk: a 2022 update","volume":"51","author":"Goldsborough","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1479164110383063","article-title":"Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and nonstatin-treated type 2 diabetes","volume":"7","author":"Younis","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","volume":"34","author":"Bekkering","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2008.04.036","article-title":"Glycation of LDL in nondiabetic people: small dense LDL is preferentially glycated both in vivo and in vitro","volume":"202","author":"Younis","year":"2009","journal-title":"Atherosclerosis"},{"key":"R53-20250729","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1479164119826479","article-title":"Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: small, dense low-density lipoprotein and interleukin-6","volume":"16","author":"Adam","year":"2019","journal-title":"Diab Vasc Dis Res"},{"key":"R54-20250729","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12986-019-0334-y","article-title":"Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation","volume":"16","author":"Fan","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"R55-20250729","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R56-20250729","doi-asserted-by":"crossref","first-page":"1094188","DOI":"10.3389\/fcvm.2023.1094188","article-title":"Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis","volume":"10","author":"Poznyak","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R57-20250729","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2022.01.005","article-title":"Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: a potential contribution to reduction in cardiovascular risk","volume":"346","author":"Iqbal","year":"2022","journal-title":"Atherosclerosis"},{"key":"R58-20250729","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacl.2017.10.011","article-title":"A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial","volume":"12","author":"Soran","year":"2018","journal-title":"J Clin Lipidol"},{"key":"R59-20250729","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/ATVBAHA.117.310368","article-title":"Lp(a) (Lipoprotein(a)) levels predict progression of carotid atherosclerosis in subjects with atherosclerotic cardiovascular disease on intensive lipid therapy: an analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL\/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report","volume":"38","author":"Hippe","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R60-20250729","doi-asserted-by":"crossref","first-page":"854624","DOI":"10.3389\/fmolb.2022.854624","article-title":"Lipoprotein(a) modulates carotid atherosclerosis in metabolic syndrome","volume":"9","author":"Cremonini","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R61-20250729","doi-asserted-by":"crossref","first-page":"416451","DOI":"10.1155\/2013\/416451","article-title":"Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study","volume":"2013","author":"Berm\u00fadez","year":"2013","journal-title":"J Diabetes Res"},{"key":"R62-20250729","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1262-3636(07)70204-5","article-title":"Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study)","volume":"31","author":"Bauduceau","year":"2005","journal-title":"Diabetes Metab"},{"key":"R63-20250729","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MCA.0b013e3282f399cf","article-title":"Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome","volume":"19","author":"Onat","year":"2008","journal-title":"Coron Artery Dis"},{"key":"R64-20250729","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.metabol.2014.08.007","article-title":"Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients","volume":"63","author":"Marzano","year":"2014","journal-title":"Metabolism"},{"key":"R65-20250729","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00125-017-4246-y","article-title":"Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes","volume":"60","author":"Berk","year":"2017","journal-title":"Diabetologia"},{"key":"R66-20250729","first-page":"270","article-title":"Lipoprotein(a) and metabolic syndrome","volume":"119","author":"Buchmann","year":"2022","journal-title":"Dtsch Arztebl Int"},{"issue":"(Suppl)","key":"R67-20250729","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1194\/jlr.R800074-JLR200","article-title":"The role of oxidized phospholipids in atherosclerosis","volume":"50","author":"Berliner","year":"2009","journal-title":"J Lipid Res"},{"key":"R68-20250729","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark Med"},{"key":"R69-20250729","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"R70-20250729","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","article-title":"Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a)","volume":"63","author":"Tsimikas","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R71-20250729","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"key":"R72-20250729","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.107.142679","article-title":"Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects","volume":"27","author":"Persson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R73-20250729","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.3390\/ijms24076458","article-title":"Age- and sex-specific association between lipoprotein-related phospholipase A2 and cardiometabolic risk factors","volume":"24","author":"Ke","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R74-20250729","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1194\/jlr.M042333","article-title":"Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease","volume":"55","author":"Talayero","year":"2014","journal-title":"J Lipid Res"},{"key":"R75-20250729","doi-asserted-by":"crossref","first-page":"e000440","DOI":"10.1161\/JAHA.113.000440","article-title":"Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele","volume":"2","author":"Olivieri","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R76-20250729","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"R77-20250729","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacl.2020.10.006","article-title":"Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes","volume":"15","author":"Buckner","year":"2021","journal-title":"J Clin Lipidol"},{"key":"R78-20250729","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J Lipid Res"},{"key":"R79-20250729","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12944-021-01580-z","article-title":"Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity","volume":"20","author":"Sun","year":"2021","journal-title":"Lipids Health Dis"},{"key":"R80-20250729","doi-asserted-by":"crossref","first-page":"21118","DOI":"10.1038\/s41598-020-77961-8","article-title":"Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test","volume":"10","author":"Garc\u00e9s","year":"2020","journal-title":"Sci Rep"},{"key":"R81-20250729","doi-asserted-by":"crossref","first-page":"e025955","DOI":"10.1161\/JAHA.122.025955","article-title":"ANGPTL3 and cardiovascular outcomes in patients with acute coronary syndrome and obstructive sleep apnea","volume":"11","author":"Lv","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R82-20250729","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1038\/s41598-021-88233-4","article-title":"The relationship between metabolic syndrome and obstructive sleep apnea syndrome: a nationwide population-based study","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"R83-20250729","doi-asserted-by":"crossref","first-page":"e001850","DOI":"10.1136\/openhrt-2021-001850","article-title":"Association between nonalcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis","volume":"8","author":"Wong","year":"2021","journal-title":"Open Heart"},{"key":"R84-20250729","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12872-021-02060-z","article-title":"Severe, but not mild to moderate, nonalcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis","volume":"21","author":"Hsiao","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"R85-20250729","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"key":"R86-20250729","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cmet.2014.08.010","article-title":"Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages","volume":"20","author":"Kratz","year":"2014","journal-title":"Cell Metab"},{"key":"R87-20250729","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10753-021-01549-1","article-title":"Inflammatory biomarkers and components of metabolic syndrome in adolescents: a systematic review","volume":"45","author":"de","year":"2022","journal-title":"Inflammation"},{"key":"R88-20250729","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"R89-20250729","doi-asserted-by":"crossref","first-page":"e17537","DOI":"10.1097\/MD.0000000000017537","article-title":"Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"R90-20250729","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/09537104.2015.1064518","article-title":"Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: a single center large-scale study","volume":"27","author":"Akboga","year":"2016","journal-title":"Platelets"},{"key":"R91-20250729","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.3390\/ijms24098414","article-title":"Assessing the relationship between systemic immune-inflammation index and metabolic syndrome in children with obesity","volume":"24","author":"Nicoar\u0103","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R92-20250729","doi-asserted-by":"crossref","first-page":"944991","DOI":"10.3389\/fendo.2022.944991","article-title":"Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R93-20250729","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/antiox10071053","article-title":"Circulating malondialdehyde concentrations in obstructive sleep apnea (OSA): a systematic review and meta-analysis with meta-regression","volume":"10","author":"Pau","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R94-20250729","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s11325-021-02557-z","article-title":"Peripheral blood oxidative stress markers for obstructive sleep apnea: a meta-analysis","volume":"26","author":"Hu","year":"2022","journal-title":"Sleep Breath"},{"key":"R95-20250729","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jc.2013-3939","article-title":"Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea","volume":"99","author":"Yadav","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R96-20250729","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2017.01512","article-title":"Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes","volume":"8","author":"Yadav","year":"2017","journal-title":"Front Immunol"},{"key":"R97-20250729","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/HYPERTENSIONAHA.122.19288","article-title":"Influence of obstructive sleep apnea severity on muscle sympathetic nerve activity and blood pressure: a systematic review and meta-analysis","volume":"79","author":"Maier","year":"2022","journal-title":"Hypertension"},{"key":"R98-20250729","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s11695-019-04377-3","article-title":"Temporal effects of bariatric surgery on adipokines, inflammation and oxidative stress in subjects with impaired glucose homeostasis at 4 years of follow-up","volume":"30","author":"Min","year":"2020","journal-title":"Obes Surg"},{"key":"R99-20250729","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/nu15092135","article-title":"Microvascular function, inflammatory status, and oxidative stress in post-bariatric patients with weight regain","volume":"15","author":"Lopes","year":"2023","journal-title":"Nutrients"},{"key":"R100-20250729","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/jcm11164910","article-title":"The effect of Roux-en-Y gastric bypass on non-alcoholic fatty liver disease fibrosis assessed by FIB-4 and NFS scores: an 11.6-year follow-up study","volume":"11","author":"Sandvik","year":"2022","journal-title":"J Clin Med"},{"key":"R101-20250729","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"key":"R102-20250729","doi-asserted-by":"crossref","first-page":"zsac210","DOI":"10.1093\/sleep\/zsac210","article-title":"The effect of obstructive sleep apnea therapy on cardiovascular autonomic function: a systematic review and meta-analysis","volume":"45","author":"Dissanayake","year":"2022","journal-title":"Sleep"},{"key":"R103-20250729","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ejim.2013.10.010","article-title":"Immediate changes in continuous positive airway pressure after bariatric surgery in obese people with obstructive sleep apnoea","volume":"25","author":"Millichamp","year":"2014","journal-title":"Eur J Intern Med"},{"key":"R104-20250729","doi-asserted-by":"crossref","first-page":"zsy028","DOI":"10.1093\/sleep\/zsy028","article-title":"The beneficial effect of weight reduction on adverse cardiovascular outcomes following bariatric surgery is attenuated in patients with obstructive sleep apnea","volume":"41","author":"Dalmar","year":"2018","journal-title":"Sleep"},{"key":"R105-20250729","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI129194","article-title":"The gut microbiome and metabolic syndrome","volume":"129","author":"Dabke","year":"2019","journal-title":"J Clin Invest"},{"key":"R106-20250729","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/antiox9080734","article-title":"Effect of Roux-en-Y bariatric bypass surgery on subclinical atherosclerosis and oxidative stress markers in leukocytes of obese patients: a one-year follow-up study","volume":"9","author":"Abad-Jim\u00e9nez","year":"2020","journal-title":"Antioxidants"},{"key":"R107-20250729","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.obpill.2022.100015","article-title":"Bariatric surgery, gastrointestinal hormones, and the microbiome: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022","volume":"2","author":"Shetye","year":"2022","journal-title":"Obesity Pillars"},{"key":"R108-20250729","doi-asserted-by":"crossref","first-page":"f5934","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus nonsurgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"key":"R109-20250729","doi-asserted-by":"crossref","first-page":"e4049","DOI":"10.1210\/clinem\/dgab398","article-title":"Time course of metabolic, neuroendocrine, and adipose effects during 2 years of follow-up after gastric bypass in patients with Type 2 diabetes","volume":"106","author":"Almby","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R110-20250729","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/db13-1307","article-title":"Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass","volume":"63","author":"Bojsen-M\u00f8ller","year":"2014","journal-title":"Diabetes"},{"key":"R111-20250729","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000696","article-title":"Metabolic and cardiovascular outcomes of bariatric surgery","volume":"31","author":"Iqbal","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"R112-20250729","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.117.032130","article-title":"Effects of bariatric surgery in obese patients with hypertension: the GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)","volume":"137","author":"Schiavon","year":"2018","journal-title":"Circulation"},{"key":"R113-20250729","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000158","article-title":"Remission and relapse of hypertension after bariatric surgery: a retrospective study on long-term outcomes","volume":"3","author":"Fisher","year":"2022","journal-title":"Ann Surg Open"},{"key":"R115-20250729","first-page":"424","article-title":"Lipoprotein modification achieved by partial ileal bypass: five-year results of the Program on the Surgical Control of the Hyperlipidemias","volume":"102","author":"Campos","year":"1987","journal-title":"Surgery"},{"key":"R116-20250729","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archinte.158.11.1253","article-title":"Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH","volume":"158","author":"Buchwald","year":"1998","journal-title":"Arch Intern Med"},{"key":"R117-20250729","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"R118-20250729","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.soard.2005.09.009","article-title":"The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients","volume":"1","author":"Zlabek","year":"2005","journal-title":"Surg Obes Relat Dis"},{"key":"R119-20250729","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2014.12.025","article-title":"Lipid profile changes in patients undergoing bariatric surgery: a comparative study between sleeve gastrectomy and mini-gastric bypass","volume":"14","author":"Milone","year":"2015","journal-title":"Int J Surg"},{"key":"R120-20250729","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.metabol.2013.09.004","article-title":"Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients","volume":"63","author":"Pich\u00e9","year":"2014","journal-title":"Metabolism"},{"key":"R121-20250729","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/2012.jama.11164","article-title":"Health benefits of gastric bypass surgery after 6\u200ayears","volume":"308","author":"Adams","year":"2012","journal-title":"JAMA"},{"key":"R122-20250729","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.2014.10706","article-title":"Long-term follow-up after bariatric surgery","volume":"312","author":"Puzziferri","year":"2014","journal-title":"JAMA"},{"key":"R123-20250729","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11695-008-9644-2","article-title":"Bariatric surgery improves atherogenic LDL profile by triglyceride reduction","volume":"19","author":"Zambon","year":"2009","journal-title":"Obes Surg"},{"key":"R124-20250729","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jacl.2020.12.002","article-title":"Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)","volume":"15","author":"Ho","year":"2021","journal-title":"J Clin Lipidol"},{"key":"R125-20250729","first-page":"1372","article-title":"Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis","volume":"18","author":"Jamialahmadi","year":"2022","journal-title":"Arch Med Sci"},{"key":"R126-20250729","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2010-2378","article-title":"Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women","volume":"96","author":"Aron-Wisnewsky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R127-20250729","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jalm\/jfaa002","article-title":"A novel cell-free fluorescent assay for HDL function: low apolipoprotein A1 exchange rate associated with increased incident cardiovascular events","volume":"5","author":"Lorkowski","year":"2020","journal-title":"J Appl Lab Med"},{"key":"R128-20250729","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040551","article-title":"Bariatric surgery improves HDL function examined by ApoA1 exchange rate and cholesterol efflux capacity in patients with obesity and Type 2 diabetes","volume":"10","author":"Lorkowski","year":"2020","journal-title":"Biomolecules"},{"key":"R129-20250729","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11695-021-05738-7","article-title":"Bariatric surgery leads to a reduction in antibodies to apolipoprotein A-1: a prospective cohort study","volume":"32","author":"Adam","year":"2022","journal-title":"Obes Surg"},{"key":"R130-20250729","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a posthoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R131-20250729","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000770","article-title":"Lipids and peripheral neuropathy","volume":"32","author":"Iqbal","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"R132-20250729","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41366-020-00727-9","article-title":"Bariatric surgery leads to an improvement in small nerve fibre damage in subjects with obesity","volume":"45","author":"Azmi","year":"2021","journal-title":"Int J Obes (Lond)"},{"key":"R133-20250729","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11695-020-05052-8","article-title":"Improvements in diabetic neuropathy and nephropathy after bariatric surgery: a prospective cohort study","volume":"31","author":"Adam","year":"2021","journal-title":"Obes Surg"},{"key":"R134-20250729","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00125-023-05899-3","article-title":"The effect of surgical weight loss on diabetes complications in individuals with class II\/III obesity","volume":"66","author":"Reynolds","year":"2023","journal-title":"Diabetologia"},{"key":"R135-20250729","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41366-020-00707-z","article-title":"Remission and progression of preexisting micro- and macroalbuminuria over 15\u200ayears after bariatric surgery in Swedish Obese Subjects study","volume":"45","author":"Shulman","year":"2021","journal-title":"Int J Obes"},{"key":"R136-20250729","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1111\/aos.14342","article-title":"Bariatric surgery might aggravate proliferative diabetic retinopathy","volume":"98","author":"Sever","year":"2020","journal-title":"Acta Ophthalmol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:03:28Z","timestamp":1753826608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000889","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}